Warnings issued to companies illegally selling E-liquid, hookah products

Warnings issued to companies illegally selling E-liquid, hookah products

Warning letters about 44 flavored e-liquid and hookah tobacco products being sold illegally in the United States have been sent to four companies, the U.S. Food and Drug Administration says.

The companies are selling the products without required marketing authorization, according to the FDA. The warning letters were sent Aug. 8 to the following companies: Mighty Vapors LLC DBA Ovo Manufacturing & Distributing; Liquid Labs LLC U.S. DBA Likido Labs U.S.; V8P Juice International LLC; and Hookah Imports Inc.

The companies were given 15 working days to respond to the FDA about how they intend to correct the violations. Failure to do so may lead to further measures such as seizure or injunction. The FDA said the letters were sent as part of its efforts against illegally marketed that have played a role in the epidemic of youth e-cigarette use.

"Today's actions make clear that we will continue to keep a close watch on whether companies are breaking the law and will take swift steps when violations are found. Our work in this area has already resulted in a number of companies removing products from the market," Acting FDA Commissioner Ned Sharpless, M.D., said in an agency news release. "The marketing of illegal products is particularly concerning given the epidemic of youth vaping that we're facing, which we know has resulted in part from irresponsible practices of manufacturers, importers, and retailers who have targeted kids in their marketing of these products."

Explore further

FDA warns 17 companies about illegal Alzheimer disease products

More information: More Information

Copyright © 2019 HealthDay. All rights reserved.

Citation: Warnings issued to companies illegally selling E-liquid, hookah products (2019, August 9) retrieved 23 May 2022 from https://medicalxpress.com/news/2019-08-issued-companies-illegally-e-liquid-hookah.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Feedback to editors